Status:
NOT_YET_RECRUITING
"Pseudo-scanner" MRI Sequences for the Detection of Bone Lesions in Multiple Myeloma
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Collaborating Sponsors:
General Electric
Conditions:
Multiple Myeloma Bone Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Recent work has confirmed the diagnostic performance of pseudo-CT sequences for detecting osteolytic lesions. Their integration into whole body MRI (WB MRI) could transform the diagnostic approach to ...
Detailed Description
Currently recommended imaging techniques for detecting bone lesions include whole-body MRI (WB-MRI), computed tomography (CT), and PET-CT. WB-MRI and PET-CT outperform CT for assessing treatment respo...
Eligibility Criteria
Inclusion
- Patient with newly diagnosed multiple myeloma, for whom bone imaging is required for staging.
- Recurrent patient after intensive treatment (high dose chemotherapy, bone marrow transplant, etc.).
- Patient requiring a PET / CT considered as the technique of choice in these stages of the disease.
Exclusion
- Implanted material incompatible with MRI.
- Severe claustrophobia.
- Pregnant women
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06988020
Start Date
June 1 2025
End Date
November 1 2027
Last Update
May 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires Saint Luc
Brussels, Belgium, 1200
2
Cliniques universitaires Saint-Luc
Brussels, Belgium